Building the future…. Giltech

2 Company founded in 1984 Three core technology platforms: Alginates Water soluble glasses Biodegradable haemo-compatible polymers and composites Giltech invented Sorbsan ®, a pioneering and breakthrough product. In addition, Giltech has invented Arglaes ® and Silverline ®, improving patient lives Over 120 years of product development experience, ISO & GMP certified…….. The History of Giltech …

3 Our mission….Design, develop and manufacture unique medical technologies that benefits patients, clinicians and payers We work with partners in the creation and realisation of medical technologies Areas we are currently working in: Woundcare Urinary Giltech today…

Our technology solutions * Granted patent: US /EP Patented* technology for production of alginate foams as advanced woundcare products Builds on Giltech’s legacy and history in use of alginates in advanced woundcare (Sorbsan®) Developed with Europe’s leading woundcare experts A highly effective anti- microbial material Based on silver ion release from soluble ‘phosphate glass’ Giltech has exclusive in- house formulation and manufacturing (ISO13485) know-how for Corglaes® Ag, built up over 25 years. Corglaes® Ag Silverline™ is a device clinically proven to reduce Indwelling Catheter-Associated Urinary Tract Infection (CAUTI) by up to 53% Silverline™ contains a small amount of CorGlaes® Ag, a powerful silver ion releasing antimicrobial agent. Silverline™

5 Significant market need for a product that overcomes the challenges of traditional products. Molvacor takes the best of each category… Natural foam alginate that promotes healing Absorbs and retains fluid better than leading brands Gentle vertical expansion to fill and conform to the wound bed with no lateral wick One-piece removal Glycerol maintains moisture in contact to promote healing and reduce pain on removal Designed with Leading European Clinical Experts Designed to be different! Combines all of the essential elements of wound healing!

6 Feature / Product Absorption has a limited impact on dressing shape Ability to reduce 'Dead Space' One piece removal High fluid retention rate High fluid absorption over wear time Actively promotes healing Molvacore Kaltostat Acquacel Sorbsan Biatain Allevyn Polymem

7 Molvacor to be launch in Europe Q4 2014, USA Q1 2015, Asia? Molvacor will be supplied sterile, CE-certified and 510K (FDA) approved. Molvacor will be available as a plain dressing and with an adhesive backing Molvacor is a platform technology to deliver anti-microbial, (Ag+ or PHMB) and odour reducing technologies

Our technology solutions * Granted patent: US /EP Patented* technology for production of alginate foams as advanced woundcare products Builds on Giltech’s legacy and history in use of alginates in advanced woundcare (Sorbsan®) Developed with Europe’s leading woundcare experts A highly effective anti- microbial material Based on silver ion release from soluble ‘phosphate glass’ Giltech has exclusive in- house formulation and manufacturing (ISO13485) know-how for Corglaes® Ag, built up over 25 years. Arglaes ® Ag Silverline™ is a device clinically proven to reduce Indwelling Catheter-Associated Urinary Tract Infection (CAUTI) by up to 53% Silverline™ contains a small amount of CorGlaes® Ag, a powerful silver ion releasing antimicrobial agent. Silverline™

9 Topical powder dressing All contain Giltech proprietary anti- microbial agent (Corglaes Ag) Delivers pure silver ions precisely at the point of need. Licensed to Medline Industries Inc $5bn global enterprise, largest private distributor in US Sold in USA, Canada and Mexico Giltech are looking for Asia distributor

Our technology solutions * Granted patent: US /EP Patented* technology for production of alginate foams as advanced woundcare products Builds on Giltech’s legacy and history in use of alginates in advanced woundcare (Sorbsan®) Developed with Europe’s leading woundcare experts A highly effective anti- microbial material Based on silver ion release from soluble ‘phosphate glass’ Giltech has exclusive in- house formulation and manufacturing (ISO13485) know-how for Corglaes® Ag, built up over 25 years. Silverline™ is a device clinically proven to reduce Indwelling Catheter-Associated Urinary Tract Infection (CAUTI) by up to 53% Silverline™ contains a small amount of CorGlaes® Ag, a powerful silver ion releasing antimicrobial agent. Silverline™Arglaes ® Ag

11 Silverline™ is a device clinically proven to reduce Indwelling Catheter-Associated Urinary Tract Infection (CAUTI) by up to 53% Silverline™ contains a small amount of CorGlaes® Ag, a powerful silver ion releasing antimicrobial agent. Sufficient silver ions also adhere to all of the distal internal surfaces of the drainage system creating a silver lining which prevents biofilm formation. Silverline™

What are we looking for?

13 Licensing or Distribution of the unique Giltech Product Portfolio Patented Technology Proven technology Developed to be the best! What are we looking for? Silverline™Arglaes ® Ag